Literature DB >> 17548563

Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.

Suhayl Dhib-Jalbut1.   

Abstract

Substantial evidence supports autoimmune activity as the etiologic mechanism underlying multiple sclerosis (MS). Both the innate and the adaptive arms of the immune system are involved in the aberrant response to several antigens associated with the myelin sheath and oligodendrocytes (OGCs) after the activation of immune cells by self- or cross-reactive microbial pathogens. The CD4(+) Th1 cell, in particular, has been implicated, but it is abetted by a variety of other cell types (CD8(+) cells, B cells, macrophages, and microglia) and soluble products (proteases, cytokines, and nitric oxide [NO]) that act both outside of and within the CNS. This review describes recent and salient findings from animal models and human clinical studies that have established our current understanding of the distinct steps in the development of immune autoreactivity that culminates in the CNS lesions associated with MS.

Entities:  

Mesh:

Year:  2007        PMID: 17548563     DOI: 10.1212/01.wnl.0000275228.13012.7b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

Review 1.  Biomarker studies in multiple sclerosis: from proteins to noncoding RNAs.

Authors:  Xiao-Fang Liu; Yue-Bei Luo; Zhao-Hui Luo; Huan Yang
Journal:  Neurochem Res       Date:  2014-07-29       Impact factor: 3.996

2.  Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.

Authors:  M Kelly Guyton; Arabinda Das; Supriti Samantaray; Gerald C Wallace; Jonathan T Butler; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

3.  Increased spontaneous apoptosis of rat primary neurospheres in vitro after experimental autoimmune encephalomyelitis.

Authors:  Mir Sajad; Jamil Zargan; Jyoti Sharma; Raman Chawla; Rajesh Arora; Sadiq Umar; Haider A Khan
Journal:  Neurochem Res       Date:  2011-03-30       Impact factor: 3.996

Review 4.  The mechanism of action of interferon-β in relapsing multiple sclerosis.

Authors:  Bernd C Kieseier
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

Review 5.  Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence.

Authors:  In Young Choi; Changhan Lee; Valter D Longo
Journal:  Mol Cell Endocrinol       Date:  2017-01-28       Impact factor: 4.102

Review 6.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 7.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

8.  Ameliorating Effect of Osteopontin on H2O2-Induced Apoptosis of Human Oligodendrocyte Progenitor Cells.

Authors:  Neda Mazaheri; Maryam Peymani; Hamid Galehdari; Kamran Ghaedi; Ali Ghoochani; Abbas Kiani-Esfahani; Mohammad Hossein Nasr-Esfahani
Journal:  Cell Mol Neurobiol       Date:  2017-11-06       Impact factor: 5.046

9.  Regulation of autoimmune arthritis by the pro-inflammatory cytokine interferon-gamma.

Authors:  Eugene Y Kim; Howard H Chi; Mohammed Bouziane; Amitabh Gaur; Kamal D Moudgil
Journal:  Clin Immunol       Date:  2008-02-13       Impact factor: 3.969

10.  Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.

Authors:  Zohara Sternberg; Kailash Chadha; Alicia Lieberman; Allison Drake; David Hojnacki; Bianca Weinstock-Guttman; Frederick Munschauer
Journal:  J Neuroinflammation       Date:  2009-10-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.